Test Price
2,800 AED✅ Home Collection Available
TALDO1 Gene Transaldolase Deficiency Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TALDO1 لنقص الترانسالدولاز في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑certified NGS processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection through ISO‑certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy, available 8 AM–11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by DHA‑licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي:
- دقة تشخيصية تصل إلى 99.9% عبر تقنية التسلسل من الجيل التالي المعتمدة دولياً.
- خدمة سحب منزلي على أعلى مستوى وفق سلسلة تبريد معتمدة من هيئة الصحة بدبي، متوفرة من 8 صباحاً حتى 11 مساءً.
- استشارة طبية هاتفية بعد الفحص لتفسير النتائج من قبل أطباء مرخصين.
- تحقق مباشر من التغطية التأمينية عبر واتساب على الرقم +971545488731.
Comprehensive TALDO1 Gene Sequencing: Unambiguous Diagnosis of Transaldolase Deficiency
This test screens the entire coding sequence of the TALDO1 gene using Next‑Generation Sequencing (NGS) to detect pathogenic variants causing transaldolase deficiency – a rare autosomal recessive inborn error of the pentose phosphate pathway. في الإمارات، يُقدم التحليل وفق أعلى معايير هيئة الصحة بدبي ويُستخدم لتأكيد التشخيص وراثياً أو لفحص أفراد العائلة الحاملين للمرض.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | Full‑gene NGS with 100 bp read depth; detects SNVs, indels, and exon‑level CNVs | Targeted mutation panel (limited to common variants) |
| Methodology | NGS (Illumina® platform) + Sanger confirmation | Sanger sequencing of selected exons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocol
“A positive TALDO1 result requires clinical correlation with metabolic profiles and liver function. Even when the genetic finding is clear, a comprehensive clinical evaluation remains essential to determine disease severity and guide management. Please consult your specialist before making any treatment decisions.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic results inform long‑term care but must not replace ongoing medical supervision.
- Exclusion Criteria: Recent blood transfusion (<2 weeks); active severe infection; inability to provide informed consent.
- Emergency Red Flags: If the patient develops acute metabolic crisis (seizures, hypoglycaemia, severe acidosis) after sample collection, seek emergency care immediately and notify the laboratory.
- Pre‑test Requirement: A genetic counselling session and a family pedigree chart must be completed before sample submission, in compliance with UAE Federal Decree‑Law No. 41 of 2024, Art. 87.
UAE Regulatory & Accreditation Compliance
- Federal Decree‑Law No. 41 of 2024 (Art. 87): All genetic data handled under strict medical confidentiality and patient data sovereignty.
- CDS Law 2026 (Minors): Genetic testing of minors requires legal guardian’s documented consent and paediatric genetic counselling.
- UAE PDPL (Federal Decree‑Law No. 45 of 2021): Personal data processed solely for diagnostic purposes, with zero data sharing without explicit consent.
- ISO 9001:2015 Certification: INT/EGQ/2509DA/3139 – Quality management system covering genomic sequencing and pre‑analytical logistics.
- Facility License: 9834453, DHA‑approved genomic laboratory.
Clinical Specialists & Intent
Three high‑relevance specialists drive this test’s clinical utility:
General Physician
First‑line recognition of hepatosplenomegaly, dysmorphism, and unexplained neonatal jaundice; triage to genetics.
Primary Care Doctor
Long‑term metabolic monitoring and family screening; identification of carriers in high‑risk consanguineous families.
Medical & PhD Researcher
Genotype‑phenotype correlation studies, drug discovery, and population genetic screening of pentose pathway disorders.
Patient FAQ & Clinical Guidance
Q1: How accurate is this TALDO1 NGS test for confirming transaldolase deficiency?
Our NGS platform detects over 99.9% of pathogenic single‑nucleotide variants and indels across the entire TALDO1 gene, providing a definitive molecular diagnosis when combined with clinical findings. يكشف اختبار التسلسل الجيني الكامل لجين TALDO1 بدقة تزيد عن 99.9% من الطفرات المسببة للمرض، مما يمنح تشخيصاً جزيئياً نهائياً عند ربطه بالعلامات السريرية.
Q2: What sample types are accepted, and how should I prepare?
We accept 2–3 mL of whole blood (EDTA), extracted DNA, or a dried blood spot on an FTA card; no fasting is required, but a genetic counselling session is mandatory before collection. نستقبل 2–3 مل من الدم الكامل، أو حمضاً نووياً مستخلصاً، أو بقعة دم جافة على بطاقة FTA؛ لا حاجة للصيام لكن جلسة الاستشارة الوراثية إلزامية قبل السحب.
Q3: Will my insurance cover the 2800 AED cost, and how quickly will I receive results?
The test is reimbursable by major UAE insurers; we provide direct billing verification before scheduling, and results are reported within 3–4 weeks via secure portal. يتم استرداد تكلفة التحليل (2800 درهم) من شركات التأمين الكبرى؛ نتحقق من التغطية قبل الحجز وتصدر النتائج خلال 3–4 أسابيع عبر بوابة آمنة.
Book Your TALDO1 Gene
Home Collection 8 AM–11 PM | WhatsApp Insurance Check
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians